There are 2,304 papers on frailty index in aging research: 78 trials and 1,880 observational studies in people, 100 in animals, 186 reviews. The newest story, Nov 13, 2026: “Low vitamin D linked to greater frailty in adults”.
Higher frailty index is associated with mortality, incident stroke and osteoporosis in human cohorts, and with prolonged hospitalization in patients with fragility fractures. A human trial reports that a multidomain lifestyle intervention decreases the index; one study in female mice links it with mortality.
1,191 findings in 704 papers from 2005 to 2026, 121 of them since April 2026
“In pooled analyses for all included trials, a 0.1-point increase in the FI was associated with an increased incidence of adverse events (IRR 1.44, 95% CI 1.35–1.54, p < 0.0001”
Education is linked with lower frailty index in humans (OR 0.846, 95% CI 0.815-0.878).
“EA significantly reduced the risk of biological aging, frailty index (odds ratio [OR]IVW = 0.846, 95% confidence interval [CI]: 0.815-0.878; P = 2.23 × 10-18)”
Education is linked with lower frailty index in humans (β = -0.477, 95% CI: -0.634 to -0.319).
“age completed full time education (β = -0.477, 95% confidence interval [CI]: -0.634 to -0.319) and average total household income before tax (β = -0.321, 95% CI: -0.410 to -0.232) were negatively associated with the frailty index”
Green space is linked with lower frailty index in humans (at 66.6% coverage (protective effect interval 0.466 to 0.784)) (-0.006 (95% CI: -0.009, -0.004)).
“reducing FI by 0.006 (95% CI: -0.009, -0.004)”
Humansat 66.6% coverage (protective effect interval 0.466 to 0.784)
Green space is linked with lower frailty index in humans (-0.3-point).
“each 1 m2 increase in green space per capita predicted a 0.8-point reduction in depression scores (95% CI: -1.2 to -0.4) and 0.3-point lower frailty index.”
Sleep duration is linked with lower frailty index in humans (cross-sectional study, fully adjusted) (β = -0.83, p < 0.001).
“A negative correlation was identified between the both night and total sleep duration and FI (night: β = -0.83, p < 0.001; total: β = -0.66, p < 0.001)”
Multidomain lifestyle intervention decreases frailty index in humans (-0.014 (95% CI -0.019, -0.008)).
“Averaged over follow-up, the reductions were −0.014 [95% confidence interval −0.019, −0.008] P <.0001 greater for Structured compared to Self-Guided participants.”
The journals of gerontology. Series A, Biological sciences and medical sciences·
Multidomain lifestyle intervention decreases frailty index in humans (difference averaging -0.014 [-0.019, -0.008] (P < .0001)).
“At 24 months, the mean (standard error) changes from baseline of a 31-component mFI were -0.009 (0.002) for Self-Guided and -0.024 (0.002) for Structured participants, a difference averaging -0.014 [-0.019, -0.008] (P < .0001).”
Digital behavior change intervention decreases frailty index in humans (nonfrail community-dwelling adults aged 60+) (-0.044 (95% CI -0.076 to -0.012)).
“The intervention group had a mean FI change of -0.044 [95% confidence interval (CI) -0.076 to -0.012]”
Human trialnonfrail community-dwelling adults aged 60+6 monthsn = 60
Quadrimodal prehabilitation decreases frailty index in humans (advanced oncogynecologic disease).
“The results demonstrated statistically significant enhancements in physical fitness assessments, a decline in the frailty index, and an augmentation in psychological well-being.”
Human trialadvanced oncogynecologic disease3-weekfemalesn = 32
Hybrid model of care decreases frailty index in humans (community-dwelling older persons) (-0.19 points).
“From the DID analysis, a reduction of 0.19 points of frailty index was observed (even after adjustment for co-variates) in the intervention group, as compared to the control group.”
Human trialcommunity-dwelling older persons15 monthsn = 128
Frailty index was not clearly linked with mortality in humans (older adults with type 2 diabetes mellitus in nursing homes, adjusted for age and sex) (HR = 1.03; 95% CI: 0.99-1.07; p = 0.139).
“not significantly associated with time to death in the Cox model (Hazard Ratio [HR] = 1.03; 95% CI: 0.99-1.07; p = 0.139).”
Humansolder adults with type 2 diabetes mellitus in nursing homes, adjusted for age and sex12-month42.6% malesn = 94
Frailty index is linked with stroke in humans (between hyperuricemia and incident stroke) (10.82% (95% CI: 6.51%-21.65%)).
“Mediation analysis further indicated that the FI partially mediated the relationship between hyperuricemia and incident stroke, accounting for 10.82% (95% CI: 6.51%-21.65%) of the total effect.”
Humansbetween hyperuricemia and incident stroken = 7,462
Frailty index is linked with worse physical function in humans (advanced non-small cell lung cancer receiving systemic therapy) (adjusted OR 2.29, 95% CI, 1.09-4.78).
“functionally decline (adjusted OR 2.29, 95% CI, 1.09-4.78)”
Humansadvanced non-small cell lung cancer receiving systemic therapyn = 155
Frailty index was not clearly linked with cardiovascular mortality in humans (diabetic patients) (OR 1.139, 95%CI (0.794, 1.634)).
“correlation between frailty and CVD mortality lost significance after adjusting for possible confounding factors [OR 1.139, 95%CI (0.794, 1.634), P > 0.05]”
Frailty index increases neuroticism in silico (IVW beta: 0.28, 95%CI: 0.21 to 0.35, P = 1.3E-16).
“genetically-determined higher frailty index was significantly associated with higher neuroticism score (IVW beta: 0.28, 95%CI: 0.21 to 0.35, P = 1.3E-16)”
Frailty index was not clearly linked with other unspecified abdominal hernias in humans (Two-sample Mendelian randomization).
“Frailty is associated with an increased risk of hiatal hernia but has no causal association with femoral hernia, inguinal hernia, or other unspecified abdominal hernias.”
Frailty index was not clearly linked with inguinal hernia in humans (Two-sample Mendelian randomization).
“Frailty is associated with an increased risk of hiatal hernia but has no causal association with femoral hernia, inguinal hernia, or other unspecified abdominal hernias.”
Frailty index decreases HbA1c reduction in humans (SGLT2 inhibitors and GLP1 receptor agonists) (0.08%-point (SGLT2 inhibitors) and 0.14%-point (GLP1 receptor agonists) smaller reduction per 0.1-point FI increase).
“there was a small attenuation in efficacy on HbA1c with increasing frailty”
Human trialSGLT2 inhibitors and GLP1 receptor agonists
Major depressive disorder is linked with higher frailty index in humans (beta 0.232, 95% CI 0.189-0.274).
“In the reverse MR test, genetic liability to MDD (beta 0.232, 95 % CI 0.189-0.274, P = 1.00 × 10−26) and neuroticism (beta 0.128, 95 % CI 0.081-0.175, P = 8.61 × 10−8) were significantly associated with higher FI.”
Hypertension is linked with higher frailty index in humans (difference, 2.69 [95% CI, 2.43-2.95]).
“participants who developed hypertension experienced greater increases in frailty index rescaled to a 0 to 100 scale than matched controls without hypertension (difference, 2.69 [95% CI, 2.43-2.95]).”
Childhood body mass index increases frailty index in silico (β per SD increase = 0.080, 95%CI = 0.046 to 0.114, p = 3.43E-06).
“genetically predicted one SD increase in childhood BMI was associated with an elevated frailty index (β per SD increase = 0.080, 95%CI = 0.046 to 0.114, p = 3.43E-06)”
Systolic blood pressure increases frailty index in silico (β = 0.135, 95% CI = 0.093 to 0.176).
“genetic predisposition to increased SBP (β = 0.135, 95% CI = 0.093 to 0.176, P = 1.73E-10), DBP (β = 0.145, 95% CI = 0.104 to 0.186, P = 3.14E-12), and PP”
Birth weight decreases frailty index in silico (β per SD increase = -0.068, 95%CI = -0.106 to -0.030, p = 3.92E-04).
“Genetically predicted one standard deviation (SD) increase in own birth weight, but not offspring birth weight (maternal-specific), was linked to a decreased frailty index”
Neuroticism increases frailty index in silico (IVW beta: 0.53, 95%CI: 0.48 to 0.59, P = 9.3E-83).
“Genetically-predicted higher neuroticism score was significantly correlated with higher frailty index (IVW beta: 0.53, 95%CI: 0.48 to 0.59, P = 9.3E-83)”
circadian syndrome component burden is linked with higher frailty index in humans (≥6 CircS components compared with <4 components) (+0.0033 per year, 95% CI 0.0016–0.0049).
“participants with 4, 5, and ≥6 CircS components had greater annual increases in FI, with additional increases of 0.0022 (95% CI: 0.0011, 0.0033, p <0.001), 0.0020”
Humans≥6 CircS components compared with <4 components
Frailty index raises the risk of mortality in humans (frail vs non-frail individuals with acute intracerebral haemorrhage) (aHR 1.48, 95% CI 1.20-1.83).
“mortality: adjusted hazard ratio [HR] 1·48 [95% CI 1·20-1·83]”
Human trialfrail vs non-frail individuals with acute intracerebral haemorrhagen = 7,035
Frailty index raises the risk of mortality in humans after adjustment for age, sex, race, education and treatment group (hazard ratio, 1.37 [95% CI, 1.26-1.50]).
“and all-cause death (hazard ratio, 1.37 [95% CI, 1.26-1.50])”
Human trialafter adjustment for age, sex, race, education and treatment groupmedian follow-up period of 4.4 years56.7% womensn = 4,692
Frailty index is associated with mortality in humans (Adults with diabetes; per 0.1-unit increase in the 2015 Frailty Index) (Adjusted OR 1.40 per 0.1-unit higher Frailty Index, 95% CI 1.08–1.81).
“each 0.1-unit increase in the 2015 Frailty Index was associated with higher mortality odds (adjusted OR 1.40, 95% CI 1.08–1.81, P = 0.011).”
HumansAdults with diabetes; per 0.1-unit increase in the 2015 Frailty Index2015–2020n = 578
Frailty index is associated with mortality in hospitalized fragility fracture patients, severe frailty vs fit (adjusted OR 12.08 (95% CI 1.54-94.89)).
“Compared with fit patients, patients with severe frailty had higher one-year mortality (19/72 (26.4%) vs 6/99 (6.1%); adjusted OR, 12.08; 95% CI, 1.54-94.89)”
Humansin hospitalized fragility fracture patients, severe frailty vs fitn = 301
Frailty index predicts mortality in humans (models using 46 individual items versus composite FI approaches in adults with CVD) (C-index: 0.71 [0.69-0.74] vs 0.64-0.67).
“Models using 46 individual items outperformed composite FI approaches for both outcomes (C-index: 0.71 [0.69-0.74] vs 0.64-0.67).”
Humansmodels using 46 individual items versus composite FI approaches in adults with CVDn = 3,669
Frailty index is linked with a higher risk of mortality in humans (hazard ratio 1.96).
“The probability of mortality, after adjusting for age, sex and cancer type, was higher in the frail cohort compared to the non-frail cohort (hazard ratio 1.96, P = 0.027).”
Humansin patients with lung, breast, or colorectal cancer, adjusted for age, sex, and cancer typen = 464
Frailty index is linked with a higher risk of mortality in humans (older patients with CAP, mild frailty compared to robust) (HR=1.837, 95% CI: 1.043-3.236).
“mild, moderate, and severe frailty were significantly associated with mortality compared to the patients in the robust health group (mild frailty: HR=1.837, 95% CI: 1.043-3.236”
Humansolder patients with CAP, mild frailty compared to robustn = 751
↑upin humans12↑upin mice1+28% higher risk per sd increaseHR 1.203–6.33
13 studies
Frailty index raises the risk of cardiovascular disease in humans after adjustment for age, sex, race, education and treatment group (subdistribution hazard ratio, 1.18 [95% CI, 1.09-1.26]).
Frailty index is linked with a higher risk of cardiovascular disease in older adults with diabetes, compared with robust-to-robust (HR 2.04, 95% CI 1.66-2.51).
“the "pre-frail➝frail" group (HR=2.04, 95%CI: 1.66-2.51)”
Humansin older adults with diabetes, compared with robust-to-robust
Frailty index is linked with a higher risk of cardiovascular disease in humans after full adjustment; participants with CKM syndrome stages 0-3 (HR 1.33 (95% CI 1.26-1.40) per 0.1 increase in FI).
“each 0.1 increase in FI was associated with a 33% higher risk of CVD after full adjustment (HR 1.33, 95% CI 1.26-1.40)”
Humansafter full adjustment; participants with CKM syndrome stages 0-3per 0.1 increase in FI
Frailty index is linked with a higher risk of cardiovascular disease in humans (FI > 4.36 and MetS > 0.17) (HR = 1.295, 95% CI: 1.141-1.469).
“Individuals with high frailty index (FI) and high metabolic syndrome score (MetS) (FI > 4.36 and MetS > 0.17) were at the highest CVD risk (HR = 1.295, 95% CI: 1.141-1.469)”
Frailty index raises the risk of stroke in humans after adjustment for age, sex, race, education and treatment group (subdistribution hazard ratio, 1.24 [95% CI, 1.10-1.39]; per SD higher FI).
“FI was associated with a higher risk of stroke (subdistribution hazard ratio, 1.24 [95% CI, 1.10-1.39]; per SD higher FI)”
Human trialafter adjustment for age, sex, race, education and treatment groupmedian follow-up period of 4.4 years56.7% womensn = 4,692
Frailty index is linked with a higher risk of stroke in humans (higher cumulative FI) (trend P < 0.0001).
“Additionally, higher cumulative FI was strongly associated with increased stroke incidence, with a significant dose-response relationship (all trend P-values < 0.0001).”
Frailty index predicts dementia in humans (differentiating cognitively normal controls from dementia patients) (AUC of 0.94).
“A model including age, sex, and aFI achieved an area under the curve (AUC) of 0.94 for differentiating cognitively normal controls (CN) from dementia patients in a held-out test set.”
Humansdifferentiating cognitively normal controls from dementia patients
Frailty index predicts dementia in humans (P < .003).
“Residents who developed dementia after admission to long-term care had higher baseline FI-t and FI-a (P's < .003) than those who remained without dementia”
Frailty index is associated with cardiovascular mortality in humans (Cardiovascular-kidney-metabolic syndrome; per 10-unit increase in frailty index) (54% higher risk per 10-unit increase; HR 1.54, 95% CI 1.24–1.91).
“each 10-unit increase in the FI was associated with a 54% higher risk of CVD mortality (HR = 1.54, 95% CI: 1.24-1.91; P < 0.001)”
HumansCardiovascular-kidney-metabolic syndrome; per 10-unit increase in frailty index
Frailty index is linked with a higher risk of cardiovascular mortality in humans (prediabetic individuals) (OR 5.985, 95%CI (5.188, 6.904)).
“significant positive correlation between the frailty index and the increased risk of CVD mortality among non-diabetic [OR 3.095, 95%CI (2.858, 3.352), P < 0.001] and prediabetic [OR 5.985, 95%CI (5.188, 6.904), P < 0.001]”
Frailty index is linked with a higher risk of cardiovascular mortality in individuals with type 2 diabetes (HR 1.66, 95% CI 1.18-2.33, P = 0.003).
“frailty T2DM increased all-cause (HR, 1.86; 95% CI 1.55-2.24; P < 0.0001) and cardiovascular (HR 1.66; 95% CI 1.18-2.33; P = 0.003) mortality and compared to non-frailty T2DM.”
Humansin individuals with type 2 diabetesmedian follow-up of 6.75 years
Journal of the American Medical Directors Association·
Frailty index is associated with frailty in humans (heart failure).
“a higher frailty index was associated with a higher prevalence in all domains of cognitive, physical, and social frailty defined by the phenotype model.”
Hypertension is associated with frailty index in humans (incident/progressive hypertension vs persistent no hypertension) (β = 0.013, 95% CI: 0.006-0.020).
“incident/progressive hypertension (β = 0.013, 95% CI: 0.006-0.020), remission/fluctuation hypertension (β = 0.009, 95% CI: 0.003-0.015), and persistent hypertension (β = 0.008, 95% CI: 0.002-0.014) were associated with higher FI.”
Humansincident/progressive hypertension vs persistent no hypertensionn = 6,770
Frailty index is linked with a higher risk of hypertension in humans (OR 1.08-1.09, P < 0.001 per 0.01 increase).
“Higher baseline frailty level was associated with a greater likelihood of hypertension and heart disease at follow-up, with covariate-adjusted odds ratios of 1.08-1.09 (all, P < 0.001) for a 0.01 increase in frailty index score.”
American journal of physiology. Heart and circulatory physiology·
Hypertension is associated with frailty index in humans (beta 1.406, 95% CI 1.225-1.587).
“genetically determined hypertension (beta: 1.406 [1.225-1.587]), MI (beta: 0.045 [0.023-0.067]), HF (beta: 0.105 [0.066-0.143]) and AF (beta: 0.021 [0.012-0.031]) were significantly associated with high FI”
Nutrition, metabolism, and cardiovascular diseases : NMCD·
Frailty index is linked with a higher risk of hypertension in humans (OR 1.07, 95% CI 1.05-1.08).
“genetically determined high FI was significantly associated with increased risks of hypertension (odds ratio [OR] per 1-SD increase: 1.07 [95 % confidence interval, 1.05-1.08])”
Frailty index is linked with a higher risk of osteoarthritis in humans (moderate combined frailty and depressive symptom burden in HRS) (HR 1.50, 95% CI 1.28-1.76).
“In fully adjusted HRS models, the HRs were 1.50 (95% CI, 1.28-1.76) for the moderate-burden group”
Humansmoderate combined frailty and depressive symptom burden in HRS8 yearsn = 3,822
Frailty index is associated with osteoarthritis in humans (OR 1.73, 95% CI 1.52-1.97).
“Higher baseline frailty was associated with development of OA by 3-, 5-, and 9-year follow-up (all P < 0.001), with the greatest effect at 9 years (odds ratio [OR] 1.73, 95% CI 1.52-1.97, P < 0.001).”
Frailty index is linked with a higher risk of osteoarthritis in humans (OR = 1.47, 95% CI = 1.21 to 1.78).
“Genetically determined FI was significantly associated with an increased risk of all OA [odds ratio (OR) = 1.47, 95% confidence interval (CI) = 1.21 to 1.78, P < 0.001]”
Frailty index raises the risk of osteoarthritis in silico (UK Biobank) (OR 1.03, 95% CI: 1.01-1.05).
“Our results denoted a genetic association between the frailty index with an increased risk of OA, the odds ratio (OR)IVW in the UKB was 1.03 (95% confidence interval [CI]: 1.01-1.05; P = 0.007)”
Frailty index is linked with a higher risk of delirium in humans (major non-cardiac surgery, adjusted for comorbidities) (RR 2.13, 95% CI 1.23-3.70).
“Frailty index, but not phenotype, was independently associated with delirium after adjustment for comorbidities (relative risk [RR] 2.13, 95% confidence interval [CI] 1.23-3.70”
Humansmajor non-cardiac surgery, adjusted for comorbiditiesn = 505
Frailty index predicts delirium in humans (AUC 0.701).
“Both the cumulative deficit frailty index and the clinical frailty scale on admission, plus age, sex, and APACHE III (AP III) score were able to discriminate between patients”
Frailty index raises the risk of delirium in silico (OR 2.85, 95% CI 1.03-7.90, P= .04).
“MR analysis found a causal association between genetically predicted FI and an elevated risk of delirium in IVW (odds ratio [OR]: 2.85; 95% CI: 1.03-7.90; P= .04).”
Frailty index is associated with all-cause adverse events in humans (IRR 1.44, 95% CI 1.35–1.54).
“In pooled analyses for all included trials, a 0.1-point increase in the FI was associated with an increased incidence of adverse events (IRR 1.44, 95% CI 1.35–1.54, p < 0.0001”
Frailty index is associated with healthcare costs in humans (established type 2 diabetes and overweight or obesity) (+$714 (42%) medication, +$244 (22%) outpatient, +$800 (134%) hospitalization, p < 0.001).
“those in the highest tertile (most frail) at Year 1 averaged $714 (42%) higher medication costs, $244 (22%) higher outpatient costs, and $800 (134%) higher hospitalization costs (p < 0.001)”
Human trialestablished type 2 diabetes and overweight or obesity1 year
Frailty index raises the risk of major disability in humans (frail vs non-frail individuals with acute intracerebral haemorrhage) (aOR 1.73, 95% CI 1.40-2.14).
“major disability among survivors: adjusted odds ratio 1·73 [1·40-2·14] for frail vs non-frail individuals”
Human trialfrail vs non-frail individuals with acute intracerebral haemorrhagen = 7,035
Human cohorts link higher frailty index to mortality and incident stroke, osteoporosis, and cardiometabolic multimorbidity. A human trial reports that a multidomain lifestyle intervention decreases the index over 24 months. A mouse study reports that the index predicts mortality in females.
Higher frailty index predicts mortality in human cohorts and is associated with incident stroke, osteoporosis, and cardiometabolic multimorbidity. It also predicts mortality in a study of female mice; studies in aged mice report reductions in frailty index with glibenclamide or LAV-BPIFB4 gene therapy.
Summary rewritten as its findings changed.
As it read before
Higher frailty index predicts mortality in human cohorts and is associated with dementia, heart failure and disability requiring long-term care. One mouse study also links the index to mortality in females. Mouse intervention studies report lower frailty index with glibenclamide in naturally aged mice and LAV-BPIFB4 gene therapy in aged mice.
Summary rewritten as its findings changed.
As it read before
Human cohorts associate higher frailty index with mortality, cardiovascular disease and dementia; higher frailty also accompanies greater disability after acute intracerebral hemorrhage. In mild cognitive impairment, higher frailty accompanies lower Alzheimer's biomarker positivity. A trial preprint reports improvement with metformin versus placebo in people with glucose intolerance.
Summary rewritten as its findings changed.
As it read before
Human cohorts associate higher frailty index with mortality, stroke, cardiovascular disease, disability and poorer cognition. A study after traumatic brain injury finds no cognitive association, despite poorer quality of life. A human trial reports reduced frailty index with metformin in older adults with glucose intolerance; in rTg4510 mice, fisetin and the dasatinib–quercetin combination increase it.
Low versus normal vitamin D was linked to a 76% higher relative risk of developing frailty in China and 27% in England.Low versus normal vitamin D was linked to a 76% higher relative risk of developing frailty in China and 27% in England.
Relative rates of developing multiple conditions were 3.40 in China and 2.62 in England for the highest-scoring quarter versus the lowest.Relative rates of developing multiple conditions were 3.40 in China and 2.62 in England for the highest-scoring quarter versus the lowest.
Who was studied7,108 adults in China and England, against adults in the lowest CTI-FI quartile
What changedRisk of multiple cardiometabolic conditions was higher with highest versus lowest combined scores: hazard ratios 3.40 (China) and 2.62 (England)
The catchSelf-reported heart disease and stroke diagnoses could misclassify who developed multiple conditions
A simplified score achieved 0.843 on a measure of risk ranking, while a fuller model outperformed frailty alone over 10 years.A simplified score achieved 0.843 on a measure of risk ranking, while a fuller model outperformed frailty alone over 10 years.
Higher versus lower frailty scores were linked to multiple heart, blood-vessel or metabolic diseases, with a hazard ratio—a relative rate measure—of 1.33.Higher versus lower frailty scores were linked to multiple heart, blood-vessel or metabolic diseases, with a hazard ratio—a relative rate measure—of 1.33.
Compared with the lowest quarter, the highest-scoring quarter had lower relative rates of cardiovascular disease (hazard ratio 0.429) and stroke (0.493).Compared with the lowest quarter, the highest-scoring quarter had lower relative rates of cardiovascular disease (hazard ratio 0.429) and stroke (0.493).